Triglyceride/High Density Lipoprotein Cholesterol Index and Future Cardiovascular Events in Diabetic Patients without Known Cardiovascular Disease
Preprint
Abstract
Background: The triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index, calculated as TG levels divided by HDL-C levels, is suggested as a predictor of cardiovascular disease (CVD). We investigated the association between the TG/HDL-C index and initial CVD events in high-risk patients with type 2 diabetes mellitus (T2DM). Methods: We analyzed the association between the TG/HDL-C index and CVD events in T2DM patients with retinopathy and hyperlipidemia without known CVD enrolled in the EMPATHY study, which compared intensive and standard statin therapy (targeting LDL-C levels n =2013) and low (TG/HDL-C n =2652) TG/HDL-C index groups. During a median follow-up of 36.8 months, 260 CVD events occurred. The high TG/HDL-C index group had higher CVD risk compared to the low TG/HDL-C index group (HR 1.89, 95% CI 1.45–2.47, p p for interaction=0.062). Intensive statin treatment was associated with reduced CVD risk compared to standard treatment in the high TG/HDL-C index group but not in the low group. Conclusions: A TG/HDL-C index ≥2.5 was associated with increased CVD risk in T2DM patients with retinopathy and hyperlipidemia without a history of CVD. The TG/HDL-C index may be a predictor of CVD and indicate patients who could benefit from intensive statin treatment.Keywords
All Related Versions
- Published version: Scientific Reports, 15 (1), 1.
This publication has 39 references indexed in Scilit:
- Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk PopulationsJAMA Cardiology, 2022
- Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to actionInternational Journal of Cardiology, 2021
- Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk PatientsHeart, Lung and Circulation, 2020
- Fibrates for primary prevention of cardiovascular disease eventsCochrane Database of Systematic Reviews, 2016
- Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemiaJournal of Clinical Lipidology, 2016
- Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) studyAtherosclerosis, 2015
- Usefulness of Triglycerides-to–High-Density Lipoprotein Cholesterol Ratio for Predicting the First Coronary Event in MenThe American Journal of Cardiology, 2009
- Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)Atherosclerosis, 2009
- Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)Atherosclerosis, 2008
- Remnant Lipoproteins Induce Endothelial Plasminogen Activator Inhibitor-1Biochemical and Biophysical Research Communications, 2001